India Health Ministry Addresses Industry Concerns About Drugs and Cosmetic Law
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - In an effort to address drug industry concerns related to inspection powers and other issues in the Drugs and Cosmetics (Amendment) Bill, India's Health Ministry says it plans to form a committee of experts to make recommendations on implementation
You may also be interested in...
India’s Draft Pharma Policy In Trouble Again
NEW DELHI - India's much-delayed draft pharmaceutical policy, which was expected to be vetted by the Group of Ministers at its latest meeting on April 30, seems to have run into rough weather yet again
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).